Endonovo Therapeutics Inc (ENDV)
0.0011
0.00 (0.00%)
USD |
OTCM |
May 17, 15:56
Endonovo Therapeutics Total Assets (Quarterly): 0.6381M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.6381M |
| September 30, 2023 | 0.8158M |
| June 30, 2023 | 1.015M |
| March 31, 2023 | 1.199M |
| December 31, 2022 | 1.281M |
| September 30, 2022 | 1.451M |
| June 30, 2022 | 1.595M |
| March 31, 2022 | 1.815M |
| December 31, 2021 | 2.007M |
| September 30, 2021 | 2.137M |
| June 30, 2021 | 2.274M |
| March 31, 2021 | 2.522M |
| December 31, 2020 | 2.607M |
| September 30, 2020 | 2.732M |
| June 30, 2020 | 2.896M |
| March 31, 2020 | 3.067M |
| December 31, 2019 | 3.275M |
| September 30, 2019 | 3.414M |
| June 30, 2019 | 4.122M |
| March 31, 2019 | 3.766M |
| December 31, 2018 | 4.242M |
| September 30, 2018 | 4.712M |
| June 30, 2018 | 4.284M |
| March 31, 2018 | 4.471M |
| Date | Value |
|---|---|
| December 31, 2017 | 4.612M |
| September 30, 2017 | 0.1602M |
| June 30, 2017 | 0.2034M |
| March 31, 2017 | 0.3584M |
| December 31, 2016 | 0.3187M |
| September 30, 2016 | 0.2645M |
| June 30, 2016 | 0.1024M |
| March 31, 2016 | 0.274M |
| December 31, 2015 | 0.4094M |
| September 30, 2015 | 0.0618M |
| June 30, 2015 | 0.0537M |
| March 31, 2015 | 0.0646M |
| December 31, 2014 | 0.0456M |
| September 30, 2014 | 0.099M |
| June 30, 2014 | 0.196M |
| March 31, 2014 | 0.186M |
| December 31, 2013 | 0.0736M |
| September 30, 2013 | 0.0639M |
| June 30, 2013 | 0.0739M |
| March 31, 2013 | 0.1064M |
| December 31, 2012 | 0.0781M |
| September 30, 2012 | 0.9685M |
| June 30, 2012 | 0.988M |
| March 31, 2012 | 1.027M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.6381M
Minimum
Dec 2023
4.122M
Maximum
Jun 2019
2.151M
Average
2.137M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 24.75M |
| Shareholders Equity (Quarterly) | -24.11M |
| Debt to Equity Ratio | -0.2934 |
| Current Ratio | 0.0008 |
| Net Debt Paydown Yield | 1.21% |